NCT07190144View on ClinicalTrials.gov

Coronary Flow Reserve Changes After Semaglutide Treatment

CompletedOBSERVATIONAL

Enrollment

122

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions

The Study Focused on the Vascular Effects of Semaglutide in Both Diabetic and Non-diabetic PatientsObesity &Amp; Overweight

Trial Locations (1)

34520

Medicana International Istanbul Hospital, Istanbul

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

MEDICANA

UNKNOWN

lead

Ekrem Bilal Karaayvaz

OTHER

NCT07190144 - Coronary Flow Reserve Changes After Semaglutide Treatment | Biotech Hunter | Biotech Hunter